Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma  Thursday April 25, 2024

EXEL vs. REGN: Which Stock Is the Better Value Option?  Thursday April 25, 2024

Regeneron (REGN) Reports Next Week: What You Should Expect  Thursday April 25, 2024

UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study  Thursday April 25, 2024

The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power  Thursday April 25, 2024

Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth  Thursday April 25, 2024

Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases  Thursday April 25, 2024

Regeneron expands in gene editing with Mammoth deal  Thursday April 25, 2024

Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks  Wednesday April 24, 2024

Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO  Wednesday April 24, 2024

Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)  Monday April 22, 2024

Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?  Monday April 22, 2024

Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution  Friday April 19, 2024

Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success  Thursday April 18, 2024

Why Investors Need to Take Advantage of These 2 Medical Stocks Now  Wednesday April 17, 2024

Why Regeneron (REGN) Could Beat Earnings Estimates Again  Tuesday April 16, 2024

UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation  Monday April 15, 2024

Regeneron to defend against DOJ complaint on drug-price manipulation  Monday April 15, 2024

Regeneron to defend US Justice Department's complaint on drug-pricing manipulation  Monday April 15, 2024

Regeneron commits $500M to new venture capital fund  Monday April 15, 2024